News18» News»India»Covid-19 Pandemic: India's Zydus Cadila Signs Pact with Gilead Sciences to Make Antiviral Drug Remdesivir
1-MIN READ

Covid-19 Pandemic: India's Zydus Cadila Signs Pact with Gilead Sciences to Make Antiviral Drug Remdesivir

Representative image.

Representative image.

Antiviral drug remdesivir is the first treatment to show improvement in COVID-19 trials.

Indian drugmaker Zydus Cadila said on Friday it signed a non-exclusive agreement with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in COVID-19 trials.

Loading...